Sees FY26 adjusted EBITDA $455M-$475M
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COLL:
- Collegium Pharmaceutical Inc. (COLL) Q4 Earnings Cheat Sheet
- Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC
- Collegium Pharmaceutical price target raised to $58 from $55 at Truist
- Collegium Pharmaceutical management to meet with Truist
- Collegium price target lowered to $56 from $58 at Barclays